Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ross

Showing results (421-430 of 587) with videos related to

Pageof 59
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyH M Kuerer, L A Newman, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
C-reactive protein as a marker of melanoma progressionShenying Fang, Yuling Wang, Dawen Sui, et al.
Cancer|February 6, 2003
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapyFunda Meric, Nadeem Q Mirza, Georges Vlastos, et al.
Cancer|September 21, 2004
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancerJennifer F Tseng, Steven J Kronowitz, Charlotte C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Innovations and challenges in melanoma: summary statement from the first Cambridge conferenceMichael B Atkins, David E Elder, Richard Essner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanomaO Eton, D D Kharkevitch, M A Gianan, et al.
Practical Radiation Oncology|December 11, 2025
Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous MelanomaNoel X Yang, Gianna L Rosamilia, Andrew J Arifin, et al.
Annals of Surgical Oncology|December 8, 2009
Factors associated with false-negative sentinel lymph node biopsy in melanoma patientsCharles R Scoggins, Robert C G Martin, Merrick I Ross, et al.
Annals of Surgery|April 25, 2006
Gender-related differences in outcome for melanoma patientsCharles R Scoggins, Merrick I Ross, Douglas S Reintgen, et al.
International Journal of Cancer|September 9, 2014
The relationship between blood IL-12p40 level and melanoma progressionShenying Fang, Yuling Wang, Yun Shin Chun, et al.
Pageof 59

Showing results (421-430 of 587) with videos related to

Sort By:
Pageof 59
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyH M Kuerer, L A Newman, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
C-reactive protein as a marker of melanoma progressionShenying Fang, Yuling Wang, Dawen Sui, et al.
Cancer|February 6, 2003
Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapyFunda Meric, Nadeem Q Mirza, Georges Vlastos, et al.
Cancer|September 21, 2004
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancerJennifer F Tseng, Steven J Kronowitz, Charlotte C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Innovations and challenges in melanoma: summary statement from the first Cambridge conferenceMichael B Atkins, David E Elder, Richard Essner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanomaO Eton, D D Kharkevitch, M A Gianan, et al.
Practical Radiation Oncology|December 11, 2025
Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous MelanomaNoel X Yang, Gianna L Rosamilia, Andrew J Arifin, et al.
Annals of Surgical Oncology|December 8, 2009
Factors associated with false-negative sentinel lymph node biopsy in melanoma patientsCharles R Scoggins, Robert C G Martin, Merrick I Ross, et al.
Annals of Surgery|April 25, 2006
Gender-related differences in outcome for melanoma patientsCharles R Scoggins, Merrick I Ross, Douglas S Reintgen, et al.
International Journal of Cancer|September 9, 2014
The relationship between blood IL-12p40 level and melanoma progressionShenying Fang, Yuling Wang, Yun Shin Chun, et al.
Pageof 59